valaciclovir mylan
adeofarma, uab - valacikloviras - plėvele dengtos tabletės - 500 mg - valaciclovir
valsartan mylan
lex ano, uab - valsartanas - plėvele dengtos tabletės - 160 mg - valsartan
ikelan
medochemie ltd. - atenololis - plėvele dengtos tabletės - 50 mg - atenolol
desmopressin sumar
sumar pharma ehf - desmopresinas - poliežuvinės tabletės - 120 µg - desmopressin
acemis
inteli generics nord, uab - acetilcisteinas - disperguojamosios tabletės - 600 mg - acetylcysteine
losartan potassium/hydrochlorothiazide stada
stada arzneimittel ag - losartano kalio druska/hidrochlorotiazidas - plėvele dengtos tabletės - 50 mg/12,5 mg - losartan and diuretics
losartan potassium/hydrochlorothiazide stada
stada arzneimittel ag - losartano kalio druska/hidrochlorotiazidas - plėvele dengtos tabletės - 100 mg/12,5 mg - losartan and diuretics
losartan potassium/hydrochlorothiazide stada
stada arzneimittel ag - losartano kalio druska/hidrochlorotiazidas - plėvele dengtos tabletės - 100 mg/25 mg - losartan and diuretics
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, žarnyno priešuždegiminiai / antiinfective agentų - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
ximluci
stada arzneimittel ag - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).